LG 50046
| Code | Size | Price |
|---|
| TAR-T32728-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
LG 50046 is a bioactive chemical.
CAS:
1703-32-8
Formula:
C17H23NO6
Molecular Weight:
337.372
Purity:
0.98
SMILES:
CCOC(=O)Oc1c(OC)cc(cc1OC)C(=O)N1CCCCC1
References
1. Landowski TH, Samulitis BK, Dorr RT. The diaryl oxazole PC-046 is a tubulin-binding agent with experimental anti-tumor efficacy in hematologic cancers. Invest New Drugs. 2013 Dec;31(6):1616-25. doi: 10.1007/s10637-013-0019-8. Epub 2013 Sep 14. PubMed PMID: 24037082; PubMed Central PMCID: PMC3899824.
2. Nor?n T, Johansson K, Unemo M. Clostridium difficile PCR ribotype 046 is common among neonatal pigs and humans in Sweden. Clin Microbiol Infect. 2014 Jan;20(1):O2-6. doi: 10.1111/1469-0691.12296. Epub 2013 Aug 8. PubMed PMID: 23927574.
3. Nambu F, Motoishi M, Omawari N, Okegawa T, Kawasaki A, Ikeda S. Inhibitory effects of OKY-046 on spasmogen-induced bronchoconstrictions in sensitized and non-sensitized guinea pigs. Jpn J Pharmacol. 1990 Feb;52(2):307-17. PubMed PMID: 2313938.
4. Kato T, Hayashi K, Takamizawa K, Tsushima N. A selective thromboxane synthetase inhibitor, OKY-046, fails to improve blood rheology in endotoxin-shocked rabbits. J Anesth. 1991 Jul;5(3):247-54. PubMed PMID: 15278626.